OXiGENE, Inc. (OXGN) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 2 ratings
View All-Time Ratings

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 10/17/2014 1 week $1.86 $2.01 +8.06% 8 Active
Comments:
Frank The Voice Frank The Voice 10/02/2014 1 month $2.14 $2.01 -6.07% -6 Active
Comments: STRONG BUY
Undiscoveredmillionaire Undiscoveredmillionaire 04/18/2014 1 week $2.80 $3.11 +11.07% 11 Ended
Comments: gradually goin up buy now out in a week see where the market does
inBestment inBestment 01/14/2014 1 month $3.03 $2.10 -30.69% -30 Ended
Comments:
andrea dardi andrea dardi 10/19/2012 1 Year $0.47 $2.75 +485.11% 485 Ended
Comments: VDA are the only possible cure for large solid cancers, where genetic inhibitors don't work
deanrusk deanrusk 10/10/2012 3 months $0.53 $4.32 +722.7% 722 Ended
Comments: Could be a diamond in the rough,but be careful here. Reverse split might be coming..
sandor baksa sandor baksa 08/11/2011 3 months $1.60 $0.56 -65% -65 Ended
Comments: This stock is undervalued
CRodriguez CRodriguez 05/13/2011 3 months $5.53 $0.56 -89.87% -89 Ended
Comments: Industry sector growing or poised for growth
Forskare Forskare 02/15/2011 3 months $0.17 $0.56 +229.41% 229 Ended
Comments: This stock is undervalued
Tiege Tiege 02/14/2011 3 months $0.16 $0.56 +250% 250 Ended
Comments: Upcoming product launch will be successful
Jöns Jöns 12/22/2009 3 months N/A Ended
Comments: An extremely underpriced stock with very promising future products where we soon will see a short squeeze seldom seen before!! A more correct stock price would be 2 – 2,50$/share.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.